Picture of DermTech logo

DMTKQ — DermTech News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapNeutral

Brief: DermTech Reports Positive Topline Results From Trust 2 Study

Jan 8 (Reuters) - DermTech Inc  DMTKW.PK :
    * DERMTECH ANNOUNCES POSITIVE TOPLINE RESULTS FROM TRUST 2
STUDY
EVALUATING THE DERMTECH MELANOMA TEST (DMT)
    * DERMTECH INC - TRUST 2 STUDY DEMONSTRATED POWERFUL
CLINICAL
UTILITY FOR DMT AS A RULE-OUT TEST FOR MELANOMA

Source text for Eikon:  ID:nBw9YFYs7a 
Further company coverage:  DMTKW.PK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on DermTech

See all news